Abstract:
Four substituted cinnamides were studied as potential inhibitors of alpha-synuclein aggregation. (E)-3-[3-(Benzo[d][1,3]dioxol-5-yl)acrylamido]benzoic acid (SMB11) was shown to inhibit amyloid fibril formation of recombinant human alpha-synuclein according to Congo Red and partial proteolysis by proteinase K assays. This compound and its analog with 3-trifluoromethylphenyl substituent demonstrated no cytotoxicity on human neuroblastoma SH-SY5Y cells.
Citation:
A. Konstantinova, V. Stroylov, D. Pozdyshev, M. Sova, S. A. Akbar, V. Muronetz, Yu. Stroylova, “Substituted cinnamides: Characterization of non-toxic inhibitors of alpha-synuclein aggregation”, Mendeleev Commun., 33:3 (2023), 334–336
Linking options:
https://www.mathnet.ru/eng/mendc389
https://www.mathnet.ru/eng/mendc/v33/i3/p334
This publication is cited in the following 2 articles: